Cary Street Partners Asset Management LLC Moderna, Inc. Transaction History

Cary Street Partners Asset Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$225.82 - $368.51 $536,322 - $875,211	-2,375 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$221.9 - $484.47 $637,518 - $1.39 Million	-2,873 Reduced 54.74%	2,375 $914,000
Q2 2021 Aug 16, 2021	SELL	$129.91 - $234.98 $2.38 Million - $4.31 Million	-18,328 Reduced 77.74%	5,248 $1.23 Million
Q1 2021 May 17, 2021	BUY	$109.18 - $185.98 $455,935 - $776,652	4,176 Added 21.53%	23,576 $744,000
Q4 2020 Feb 11, 2021	BUY	$65.74 - $169.86 $1.28 Million - $3.3 Million	19,400 New	19,400 $459,000

1,114

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Cary Street Partners Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Cary Street Partners Asset Management LLC with notifications on news.